A clinical trial to study the effects of two drugs, lignocaine and esmolol for decreasing optic nerve sheath diameter in patients undergoing laryngoscopy and endotracheal intubatio
Phase 1
- Conditions
- Health Condition 1: H470- Disorders of optic nerve, not elsewhere classifiedHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2024/03/064679
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA Grade 1 and 2
Exclusion Criteria
Patients with psychiatric illness/ any space occupying lesion in CNS, on beta blockers, known eye disease, difficult airway, allergic to lignocaine.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Optic nerve sheath diameter using ocular ultrasonographyTimepoint: Optic nerve sheath diameter before, at after 5, 10, 15 minutes of laryngoscopy and endotracheal intubation
- Secondary Outcome Measures
Name Time Method Heart rate and blood pressure valuesTimepoint: Throughout the procedure after every 10 minutes